TKT and cancer: For example, an oAdv with a promoter-dependent telomerase that expresses HSV-TK showed potency and safety both in vitro and in vivo.57 The ability of oAdv to eliminate cancer stem cells often refractory to conventional chemo/radiotherapies may provide inhibition of cancer recurrence and metastasis.58–60